Hysteroscopic treatment of cervical pregnancy: case report

Authors

  • Aarón Jiménez Valdez Department of Obstetrics and Gynecology, Naval Medical Center, Mexico
  • Sara Elia Hernadez Flores Chief of Tococirugia, Naval Medical Center, Mexico
  • Jorge Arturo Barbabosa Vilchis Department of Gynecology, Naval Medical Center, Mexico
  • Claudia Meixueiro Calderon Department of Pathology, Naval Medical Center, Mexico

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20200995

Keywords:

Cervical implantation, Ectopic pregnancies, Hysteroscopy, Methotrexate

Abstract

Of ectopic pregnancies, cervical implantation pregnancy is an exceptional entity, corresponding to less than 1% of ectopic pregnancies. With an incidence calculated at 1: 2500 to 1: 12,000 pregnancies. The risk factors for cervical pregnancy are the same as for other ectopic pregnancies. This entity, a difference from tubaric pregnancy where bleeding is within the peritoneal cavity, the main risk is incoercible vaginal bleeding, which usually ends in a hysterectomy, which limits the reproductive future of patients. There are currently no established criteria for candidates for medical versus surgical treatment. This case reports a case of cervical ectopic pregnancy, treated with Methotrexate, and culminating with hysteroscopy resection.

References

Brady PC. New evidence to guide ectopic pregnancy diagnosis and management. Obstet Gynecol Surv. 2017;72(10):618-25.

Bielak A, Hincz P, Brot A, Wojciechowska E, Borowski D, Kozarzewski M, et al. Cervical ectopic pregnancy: a case report. Ginekologia Polska. 2006;877(11):881-4.

Anate M, Ismaila GA. Cervical ectopic pregnancy: a case report. West African J Med. 1996;15(2):123-5.

Levin G, Dior UP, Shushan A, Gilad R, Benshushan A, Rottenstreich A. Risk factors for recurrent ectopic pregnancy following single-dose methotrexate treatment. Eur J Contracept Reprod Health Care. 2019;24(4):294-8.

Yang C, Cai J, Geng Y, Gao Y. Multiple-dose and double-dose versus single-dose administration of methotrexate for the treatment of ectopic pregnancy: a systematic review and meta-analysis. Reproduct Bio Med Online. 2017;34(4):383-91.

Ohannessian A, Crochet P, Courbiere B, Gnisci A, Agostini A. Methotrexate treatment for ectopic pregnancy after assisted reproductive technology: A case-control study. Gynecol Obstet Fertil. 2016;44(6):341-4.

Marret H, Fauconnier A, Dubernard G, Misme H, Lagarce L, Lesavre M, et al. Overview and guidelines of off-label use of methotrexate in ectopic pregnancy: report by CNGOF. Eur J Obstet Gynecol Reprod Biol. 2016;205:105-9.

Piccioni MG, Framarino-Dei-Malatesta M, Polidori NF, Marcoccia E. Cervical ectopic pregnancy treated with systemic methotrexate and following successful term pregnancy: case report. J Obstet Gynaecol. 2015;35(6):654-5.

Downloads

Published

2020-03-25

Issue

Section

Case Reports